1. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity
- Author
-
Esther Martinborough, Donald S. Karanewsky, Francisco J. López, Robert I. Higuchi, Min Wu, William Y. Chang, Marquis L. Cummings, Lin Zhi, Thomas Lau, Yun Oliver Long, Thomas R. Caferro, and Keith B. Marschke
- Subjects
Male ,medicine.medical_specialty ,medicine.drug_class ,Clinical Biochemistry ,Administration, Oral ,Pharmaceutical Science ,Quinolones ,Biochemistry ,Rats, Sprague-Dawley ,Structure-Activity Relationship ,Anabolic Agents ,In vivo ,Internal medicine ,Oxazines ,Drug Discovery ,Androgen Receptor Antagonists ,medicine ,Animals ,Structure–activity relationship ,Testosterone ,Receptor ,Molecular Biology ,Chemistry ,Organic Chemistry ,Prostate ,Organ Size ,Androgen ,Rats ,Androgen receptor ,Endocrinology ,Models, Chemical ,Selective androgen receptor modulator ,Receptors, Androgen ,Androgens ,Molecular Medicine ,Orchiectomy - Abstract
Modification on a lead series of [1,4]oxazino[3,2-g]quinolin-7-ones at the 2-position led to selective androgen receptor modulators with improved in vivo activity. The most potent analog (-)-33a exhibited full maintenance of levator ani muscle at 3mg/kg and reduced activity on ventral prostate weight in a 2-week orally-dosed and orchidectomized rat maintenance assay.
- Published
- 2008